Apollo Hospitals Enterprise Limited has posted impressive growth for the third quarter of FY25, driven by strong performance across its healthcare services and allied businesses. The company’s consolidated profit after tax (PAT) surged by 52% year-on-year to ₹372 crore, compared to ₹245 crore in Q3 FY24.
Q3 FY25 Consolidated Financial Highlights:
- Revenue: Consolidated revenue grew 14% YoY to ₹5,527 crore, driven by growth in healthcare services and pharmacy distribution.
- Healthcare Services (HCS) revenue: ₹2,785 crore (13% YoY growth)
- Apollo HealthCo (Pharmacy & Digital Health) revenue: ₹2,352 crore (15% YoY growth)
- Apollo Health & Lifestyle Limited (AHLL) revenue: ₹390 crore (15% YoY growth)
- Gross merchandise value (GMV) of Apollo 24/7 stood at ₹760 crore.
- EBITDA: Consolidated EBITDA rose 24% YoY to ₹762 crore, reflecting operational efficiency and business expansion.
- HCS EBITDA: ₹671 crore (14% YoY growth)
- AHLL EBITDA: ₹34 crore (32% YoY growth)
- Apollo HealthCo EBITDA: ₹57 crore
- PAT: PAT grew by 52% YoY to ₹372 crore.
- HCS contributed ₹348 crore to PAT, marking a 21% YoY increase.
YTD FY25 Consolidated Performance:
For the nine months ended December 2024, Apollo Hospitals maintained its growth trajectory:
- Revenue: ₹16,202 crore (15% YoY growth)
- HCS revenue: ₹8,326 crore (14% YoY growth)
- AHLL revenue: ₹1,160 crore (15% YoY growth)
- Pharmacy and Digital Health revenue: ₹6,717 crore (16% YoY growth)
- Apollo 24/7 GMV at ₹2,212 crore.
- EBITDA: ₹2,252 crore, up 29% YoY
- HCS EBITDA: ₹2,014 crore (14% YoY growth)
- AHLL EBITDA: ₹107 crore (32% YoY growth)
- PAT: ₹1,056 crore, up 64% YoY
Key Developments:
- Expansion: Apollo Hospitals plans to add 3,512 beds over the next 3 to 4 years, starting FY26.
- Partnerships: Collaborated with Microsoft to accelerate AI-driven healthcare innovation, focusing on disease progression and genomics.
- Cardiac Milestone: Achieved 500 robotic cardiac surgeries in Chennai and 1,000 robotic cardiac surgeries across Bangalore and Chennai.
- Interim Dividend: Declared an interim dividend of ₹9 per share.
Chairman’s Comment:
Dr. Prathap C Reddy, Chairman of Apollo Hospitals, emphasized the company’s commitment to expanding cutting-edge medical services and technology across India. “We continue to build our footprint with advanced medical innovations and collaborations, ensuring quality healthcare for all.”
Outlook:
Apollo Hospitals remains optimistic about its future, focusing on healthcare innovation, strategic collaborations, and operational growth, aligning with its mission of ‘Heal in India’ and ‘Heal by India.’
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Always consult a financial advisor before making any investment decisions.
